J Interferon Cytokine Res 2002; 22: 295–303 112 Shepherd FA, Bea

J Interferon Cytokine Res 2002; 22: 295–303. 112 Shepherd FA, Beaulieu R, Gelmon K et al. Prospective

randomized learn more trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi’s sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. J Clin Oncol 1998; 16: 1736–1742. 113 Kreuter A, Rasokat H, Klouche M et al. Liposomal pegylated doxorubicin versus low-dose recombinant interferon alfa-2a in the treatment of advanced classic Kaposi’s sarcoma; retrospective analysis of three German centers. Cancer Invest 2005; 23: 653–659. 114 Masood R, Cai J, Zheng T et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS–Kaposi?sarcoma. CHIR-99021 molecular weight Proc Natl Acad Sci USA 1997; 94: 979–984. 115 Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the [beta]-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8: 1223–1234. 116 Uldrick TS, Wyvill KM, Kumar P et al. Phase II study of bevacizumab in patients with HIV-associated Kaposi’s sarcoma receiving antiretroviral therapy. J Clin Oncol 2012; 30: 1476–1483. 117 Fife K, Howard MR, Gracie

F et al. Activity of thalidomide in AIDS-related Kaposi’s sarcoma and correlation with HHV8 titre. Int J STD AIDS 1998; 9: 751–755. 118 Little RF, Wyvill KM, Pluda JM et al. Activity of thalidomide in AIDS-related Kaposi’s sarcoma. J Clin Oncol 2000; 18: 2593–2602. 119 Koon HB, Honda K, Lee JY et al. Phase II AIDS Malignancy Consortium trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS). J Acquir Immune Defic Syndr 2011; 56: 64–68. 120 Dezube BJ, Krown SE, Lee JY et al. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi’s sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 2006; 24: 1389–1394. 121 Brinker BT, Krown SE, Lee JY et al. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter

trial of the AIDS Malignancy Consortium. Cancer 2008; 112: 1083–1088. 122 Little RF, Pluda JM, Wyvill KM et al. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi mafosfamide sarcoma. Blood 2006; 107: 4650–4657. 123 Lechowicz M, Dittmer DP, Lee JY et al. Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis 2009; 49: 1946–1949. 124 Krown SE, Roy D, Lee JY et al. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr 2012; 59: 447–454. 125 Evans SR, Krown SE, Testa MA et al. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi’s sarcoma: an AIDS Clinical Trials Group clinical study. J Clin Oncol 2002; 20: 3236–3241. 126 Zhong DT, Shi CM, Chen Q et al.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>